Sun Pharma Global FZE
USPTO Trademark & Patent Filings
Trademark applications and grants for Sun Pharma Global Fze. Sun Pharma Global Fze has 90 trademark applications. The latest application filed is for "ILUMYA"
- Company Aliases
- Sun Pharma Global FZE
- fze global pharma sun
- SUN PHARMA GLOBAL FZE - Sharjah AE
| State Incorporated | UNITED ARAB EMIRATES |
| Entity Type | Free Zone Establishment |
| Address | Executive Suite Y-43 P.O. Box No. 122304, SAIF Zone Sharjah UNITED ARAB EMIRATES |
Trademarks Patents
| Patent Application | Date |
|---|---|
| TOPICAL FORMULATIONS AND USES THEREOF 20210268114 - 17/200454 WEISS; Sidney L. | 2021-09-02 |
| METHODS FOR TREATING OCULAR INFLAMMATORY DISEASES 20210205330 - 17/206890 BOWMAN; Lyle M ; et al. | 2021-07-08 |
| TOPICAL CYCLOSPORINE-CONTAINING FORMULATIONS AND USES THEREOF 20210145924 - 17/143863 WEISS; Sidney L. ; et al. | 2021-05-20 |
| METHODS FOR TREATING OCULAR INFLAMMATORY DISEASES 20200183808 - 16/238201 BOWMAN; Lyle M. ; et al. | 2020-06-11 |
| TOPICAL FORMULATIONS AND USES THEREOF 20200009137 - 16/444474 WEISS; Sidney L. | 2020-01-09 |
| Methods for treating ocular inflammatory diseases 11,154,560 - 16/238,201 Bowman , et al. October 26, 2 | 2021-10-26 |
| Methods for treating ocular inflammatory diseases 11,154,560 - 16/238,201 Bowman , et al. October 26, 2 | 2021-10-26 |
| Methods for treating ocular inflammatory diseases 10,980,818 - 16/237,110 Bowman , et al. April 20, 2 | 2021-04-20 |
| Methods for treating ocular inflammatory diseases 10,980,818 - 16/237,110 Bowman , et al. April 20, 2 | 2021-04-20 |
| Topical cyclosporine-containing formulations and uses thereof 10,918,694 - 16/079,928 Weiss , et al. February 16, 2 | 2021-02-16 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 